Compound Library
Evidence-based research summaries across 9 categories.
Naturally occurring thymus-derived peptide. FDA-approved (Zadaxin) in 35+ countries. Most studied immune-modulating peptide with decades of clinical data in infectious disease and oncology.
Thymus-derived polypeptide complex from Khavinson Russian research program. Studied for immune restoration, longevity extension, and age-related immune decline reversal.
Only cathelicidin antimicrobial peptide in humans. Studied for broad-spectrum antimicrobial, immunomodulatory, wound healing, and potential anticancer properties.
Zinc-dependent thymic nonapeptide — only thymic hormone requiring a cofactor for activity. Studied for immune restoration, anti-inflammatory effects, and has demonstrated analgesic properties in pain models. Declines with thymic involution.
PEGylated form of thymalin with extended half-life designed for less frequent dosing. Studied for prolonged immune restoration and longevity applications. Pegylation technology applied to thymic peptide class.
Recombinant interleukin-2 at ultra-low doses studied for regulatory T-cell (Treg) expansion in autoimmune disease and immune aging. Distinct from high-dose IL-2 cancer immunotherapy — entirely different mechanism and safety profile at ultra-low doses.
Thymosin alpha-1 (Zadaxin) in extended/chronic administration research protocols — distinct from standard acute infection courses. Studied for long-term immunosenescence reversal, chronic viral infection suppression, and longevity applications in aging immune systems.